Safety, efficacy and outcome-related factors of perampanel over 12 months in a real-world setting: the FYDATA study V Villanueva, M Garcés, FJ López-González, X Rodriguez-Osorio, ... Epilepsy research 126, 201-210, 2016 | 120 | 2016 |
Perampanel in routine clinical use in idiopathic generalized epilepsy: the 12‐month GENERAL study V Villanueva, J Montoya, A Castillo, JÁ Mauri‐Llerda, P Giner, ... Epilepsia 59 (9), 1740-1752, 2018 | 101 | 2018 |
Long-term safety and efficacy of eslicarbazepine acetate in patients with focal seizures: results of the 1-year ESLIBASE retrospective study V Villanueva, JM Serratosa, E Guillamón, M Garcés, BG Giráldez, ... Epilepsy research 108 (7), 1243-1252, 2014 | 74 | 2014 |
Drug-induced sleep endoscopy: a two drug comparison and simultaneous polysomnography M Carrasco Llatas, G Agostini Porras, MT Cuesta González, ... European Archives of Oto-Rhino-Laryngology 271, 181-187, 2014 | 61 | 2014 |
Efficacy and tolerability of perampanel as a first add-on therapy with different anti-seizure drugs E Santamarina, V Bertol, V Garayoa, MJ García-Gomara, ... Seizure 83, 48-56, 2020 | 46 | 2020 |
Early add-on lacosamide in a real-life setting: results of the REALLY study V Villanueva, M Garcés, E López-Gomáriz, JM Serratosa, ... Clinical drug investigation 35, 121-131, 2015 | 37 | 2015 |
Factors influencing response to intravenous lacosamide in emergency situations: LACO-IV study M Garcés, V Villanueva, JA Mauri, A Suller, C García, FJL González, ... Epilepsy & Behavior 36, 144-152, 2014 | 35 | 2014 |
Effectiveness and safety of perampanel monotherapy for focal and generalized tonic‐clonic seizures: experience from a national multicenter registry R Toledano Delgado, I García‐Morales, B Parejo‐Carbonell, ... Epilepsia 61 (6), 1109-1119, 2020 | 29 | 2020 |
Efficacy and safety of eslicarbazepine acetate monotherapy for partial-onset seizures: experience from a multicenter, observational study R Toledano, CE Jovel, A Jiménez-Huete, PG Bayarri, D Campos, ... Epilepsy & Behavior 73, 173-179, 2017 | 21 | 2017 |
Efficacy and safety of eslicarbazepine-acetate in elderly patients with focal epilepsy: case series A Gómez-Ibáñez, JM Serratosa, E Guillamón, M Garcés, BG Giráldez, ... Seizure 48, 53-56, 2017 | 14 | 2017 |
EARLY‐ESLI study: Long‐term experience with eslicarbazepine acetate after first monotherapy failure V Villanueva, P Bermejo, J Montoya, M Toledo, A Gómez‐Ibáñez, ... Acta Neurologica Scandinavica 136 (3), 254-264, 2017 | 13 | 2017 |
MONOZEB: Long-term observational study of eslicarbazepine acetate monotherapy V Villanueva, P Bermejo, J Montoya, A Massot-Tarrús, ML Galiano, ... Epilepsy & Behavior 97, 51-59, 2019 | 9 | 2019 |
Refractory nonconvulsive status epilepticus N Torres-Cano, BP Giner, MR Chilet-Chilet, L Ruiz-Marquez, ... Revista de neurologia 53 (4), 255, 2011 | 8* | 2011 |
El valencià, una llengua del segle XXI P Giner Bayarri València: Els Fanals de la Terra, 1999 | 8* | 1999 |
Utilidad de las pruebas neurofisiológicas como apoyo al test DSM-IV en el diagnóstico de TDAH. Av Neurol [Internet]. 2011; 2: 8 P Giner Bayarri, L Ruiz Márquez, A Rodrigo Sanbartolomé | 5 | |
Recomendaciones para la realización de potenciales evocados PG Bayarri, MRC Chilet Sociedad Española de Neurofisiología Clínica, 2022 | 4 | 2022 |
Neurofeedback versus pharmacological intervention in the treatment of childhood attention deficit/hyperactivity Disorder (ADHD): First spanish clinical neuropsychological study D Medici, PG Bayarri, RC Chilet, JM Ibánez, MM Suarez-Varela, D Calvo American Journal of Applied Psychology 7 (5), 57, 2018 | 4 | 2018 |
DISE: a 2-drug comparison and simultaneous polysomnography M Carrasco, G Agostini, A Rodrigo, P Giner, F Gómez, J Dalmau Otolaryngology—Head and Neck Surgery 147 (2_suppl), P120-P120, 2012 | 4 | 2012 |
Recomendaciones para el empleo de técnicas neurofisiológicas en el diagnóstico de muerte encefálica de la Sociedad de Neurofisiología Clínica de las Comunidades de Valencia y … AV Arciniegas-Villanueva, E González-García, F Ordoño-Domínguez, ... Revista de neurologia 75 (Supl 3), S1, 2022 | 3 | 2022 |
Evolution of safety profile of different therapeutic alternatives in restless legs syndrome (rls) N Cano, P Bayarri, R Chilet, G Plaza, A Carrasco, J Ibanez Sleep Med S 14, e88, 2013 | 3 | 2013 |